BeOne Medicines annual operating expenses
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
BeOne Medicines Operating Expenses Growth & History (ONC)
BeOne Medicines's operating expenses was $4.23B for fiscal 2025.
View full BeOne Medicines company overviewBeOne Medicines annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $4.23B | $443.0M | +11.71% |
| 2024 | 2024-12-31 | $3.78B | $497.8M | +15.15% |
| 2023 | 2023-12-31 | $3.29B | $367.5M | +12.59% |
| 2022 | 2022-12-31 | $2.92B | $469.0M | +19.14% |
| 2021 | 2021-12-31 | $2.45B | $554.2M | +29.23% |
| 2020 | 2020-12-31 | $1.90B | $579.0M | +43.97% |
| 2019 | 2019-12-31 | $1.32B | $441.6M | +50.46% |
| 2018 | 2018-12-31 | $875.3M | $543.4M | +163.74% |
| 2017 | 2017-12-31 | $331.9M | $213.7M | +180.94% |
| 2016 | 2016-12-31 | $118.1M | $52.6M | +80.18% |
| 2015 | 2015-12-31 | $65.6M | $36.8M | +127.71% |
| 2014 | 2014-12-31 | $28.8M | — | — |
BeOne Medicines quarterly operating expenses
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $1.21B | $142.7M | +13.43% |
| Q1 2026 | 2026-03-31 | $1.10B | $155.1M | +16.48% |
| Q4 2025 | 2025-12-31 | $1.17B | $124.0M | +11.85% |
| Q3 2025 | 2025-09-30 | $1.05B | $101.3M | +10.64% |
| Q2 2025 | 2025-06-30 | $1.06B | $164.6M | +18.33% |
| Q1 2025 | 2025-03-31 | $941.2M | $53.1M | +5.98% |
| Q4 2024 | 2024-12-31 | $1.05B | $134.3M | +14.72% |
| Q3 2024 | 2024-09-30 | $951.4M | $132.4M | +16.17% |
| Q2 2024 | 2024-06-30 | $898.2M | $80.2M | +9.81% |
| Q1 2024 | 2024-03-31 | $888.1M | $150.8M | +20.45% |
| Q4 2023 | 2023-12-31 | $912.4M | $137.2M | +17.70% |
| Q3 2023 | 2023-09-30 | $819.0M | $69.5M | +9.28% |
| Q2 2023 | 2023-06-30 | $818.0M | $108.2M | +15.24% |
| Q1 2023 | 2023-03-31 | $737.3M | $52.6M | +7.68% |
| Q4 2022 | 2022-12-31 | $775.2M | $38.0M | +5.16% |
| Q3 2022 | 2022-09-30 | $749.4M | $128.1M | +20.61% |
| Q2 2022 | 2022-06-30 | $709.8M | $121.2M | +20.60% |
| Q1 2022 | 2022-03-31 | $684.7M | $181.7M | +36.11% |
| Q4 2021 | 2021-12-31 | $737.2M | $173.2M | +30.72% |
| Q3 2021 | 2021-09-30 | $621.4M | $111.3M | +21.81% |
| Q2 2021 | 2021-06-30 | $588.6M | $178.4M | +43.48% |
| Q1 2021 | 2021-03-31 | $503.0M | $91.4M | +22.19% |
| Q4 2020 | 2020-12-31 | $563.9M | $137.0M | +32.09% |
| Q3 2020 | 2020-09-30 | $510.1M | $167.8M | +49.02% |
| Q2 2020 | 2020-06-30 | $410.2M | $98.9M | +31.75% |
| Q1 2020 | 2020-03-31 | $411.7M | $175.3M | +74.19% |
| Q4 2019 | 2019-12-31 | $426.9M | $96.7M | +29.27% |
| Q3 2019 | 2019-09-30 | $342.3M | $145.7M | +74.11% |
| Q2 2019 | 2019-06-30 | $311.3M | $101.7M | +48.54% |
| Q1 2019 | 2019-03-31 | $236.3M | $97.5M | +70.26% |
| Q4 2018 | 2018-12-31 | $330.3M | $211.3M | +177.69% |
| Q3 2018 | 2018-09-30 | $196.6M | $93.2M | +90.20% |
| Q2 2018 | 2018-06-30 | $209.6M | $151.6M | +261.24% |
| Q1 2018 | 2018-03-31 | $138.8M | $87.3M | +169.30% |
| Q4 2017 | 2017-12-31 | $118.9M | $81.7M | +219.14% |
| Q3 2017 | 2017-09-30 | $103.4M | $68.5M | +196.78% |
| Q2 2017 | 2017-06-30 | $58.0M | $33.0M | +131.89% |
| Q1 2017 | 2017-03-31 | $51.5M | $30.5M | +145.31% |
| Q4 2016 | 2016-12-31 | $37.3M | $6.2M | +20.02% |
| Q3 2016 | 2016-09-30 | $34.8M | $19.5M | +126.57% |
| Q2 2016 | 2016-06-30 | $25.0M | $17.1M | +214.93% |
| Q1 2016 | 2016-03-31 | $21.0M | $9.8M | +87.75% |
| Q4 2015 | 2015-12-31 | $31.1M | — | — |
| Q3 2015 | 2015-09-30 | $15.4M | — | — |
| Q2 2015 | 2015-06-30 | $7.9M | — | — |
| Q1 2015 | 2015-03-31 | $11.2M | — | — |
BeOne Medicines operating expenses trends
Over the last five fiscal years, BeOne Medicines's operating expenses increased from $1.90B to $4.23B, a change of $2.33B. The latest reported quarter, Q2 2026, shows $1.21B.
About the metric
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
Calculation and source
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review BeOne Medicines source filings ↗Community posts
BeOne’s initial clinical results support planned late-stage studies
BeOne Medicines ($ONC) disclosed new dose-optimization findings for BGB-B2033 in heavily pretreated liver cancer. At the proposed Phase 3 dose, the bispecific antibody produced confirmed responses in 36% of patients, with an estimated 74.1% ...
